These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 36325129)

  • 21. Sensitivity of the lateral flow urine lipoarabinomannan assay in ambulant adults with advanced HIV disease: data from the TB Fast Track study.
    Tlali M; Fielding KL; Karat AS; Hoffmann CJ; Muravha T; Grant AD; Charalambous S
    Trans R Soc Trop Med Hyg; 2020 Aug; 114(8):556-560. PubMed ID: 32313941
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cost of point-of-care lateral flow urine lipoarabinomannan antigen testing in HIV-positive adults in South Africa.
    Mukora R; Tlali M; Monkwe S; Charalambous S; Karat AS; Fielding KL; Grant AD; Vassall A
    Int J Tuberc Lung Dis; 2018 Sep; 22(9):1082-1087. PubMed ID: 30092876
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Incremental yield and cost of urine Determine TB-LAM and sputum induction in seriously ill adults with HIV.
    Boyles TH; Griesel R; Stewart A; Mendelson M; Maartens G
    Int J Infect Dis; 2018 Oct; 75():67-73. PubMed ID: 30125689
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Accuracy of the tuberculosis point-of-care Alere determine lipoarabinomannan antigen diagnostic test using α-mannosidase treated and untreated urine in a cohort of people living with HIV in Guatemala.
    García JI; Meléndez J; Álvarez R; Mejía-Chew C; Kelley HV; Sidiki S; Castillo A; Mazariegos C; López-Téllez C; Forno D; Ayala N; Balada-Llasat JM; Mejía-Villatoro CR; Wang SH; Torrelles JB; Ikeda J
    AIDS Res Ther; 2020 Oct; 17(1):62. PubMed ID: 33076996
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lipoarabinomannan Antigen Assay (TB-LAM) for Diagnosing Pulmonary Tuberculosis in Children with Severe Acute Malnutrition in Mozambique.
    Osório DV; Munyangaju I; Muhiwa A; Nacarapa E; Nhangave AV; Ramos JM
    J Trop Pediatr; 2021 Jul; 67(3):. PubMed ID: 33038897
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical significance of lipoarabinomannan detection in urine using a low-cost point-of-care diagnostic assay for HIV-associated tuberculosis.
    Lawn SD; Kerkhoff AD; Vogt M; Wood R
    AIDS; 2012 Aug; 26(13):1635-43. PubMed ID: 22555166
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prospective Cohort Study on Performance of Cerebrospinal Fluid (CSF) Xpert MTB/RIF, CSF Lipoarabinomannan (LAM) Lateral Flow Assay (LFA), and Urine LAM LFA for Diagnosis of Tuberculous Meningitis in Zambia.
    Siddiqi OK; Birbeck GL; Ghebremichael M; Mubanga E; Love S; Buback C; Kosloff B; Ayles H; Atadzhanov M; Dheda K; Koralnik IJ
    J Clin Microbiol; 2019 Aug; 57(8):. PubMed ID: 31189584
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparative performance of urinary lipoarabinomannan assays and Xpert MTB/RIF in HIV-infected individuals.
    Shah M; Ssengooba W; Armstrong D; Nakiyingi L; Holshouser M; Ellner JJ; Joloba M; Manabe YC; Dorman SE
    AIDS; 2014 Jun; 28(9):1307-14. PubMed ID: 24637544
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Diagnostic accuracy of a point-of-care urine test for tuberculosis screening among newly-diagnosed HIV-infected adults: a prospective, clinic-based study.
    Drain PK; Losina E; Coleman SM; Giddy J; Ross D; Katz JN; Walensky RP; Freedberg KA; Bassett IV
    BMC Infect Dis; 2014 Feb; 14():110. PubMed ID: 24571362
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Accuracy of Determine TB-LAM Ag to detect TB in HIV infected patients associated with diagnostic methods used in Brazilian public health units.
    Benjamin A; Cavalcante SC; Jamal LF; Arakaki-Sanchez D; de Lima JN; Pilotto JH; de Oliveira Junior FI; Souza TNL; Lourenço MC; de Mello MB; do Brasil PEAA; Barreira D; Rolla V
    PLoS One; 2019; 14(9):e0221038. PubMed ID: 31550246
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Urine Lipoarabinomannan Testing for All HIV Patients Hospitalized in Medical Wards Identifies a Large Proportion of Patients With Tuberculosis at Risk of Death.
    Huerga H; Mathabire Rucker SC; Bastard M; Mpunga J; Amoros Quiles I; Kabaghe C; Sannino L; Szumilin E
    Open Forum Infect Dis; 2021 Feb; 8(2):ofaa639. PubMed ID: 33575422
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The potential impact of urine-LAM diagnostics on tuberculosis incidence and mortality: A modelling analysis.
    Ricks S; Denkinger CM; Schumacher SG; Hallett TB; Arinaminpathy N
    PLoS Med; 2020 Dec; 17(12):e1003466. PubMed ID: 33306694
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Predictors and outcomes of mycobacteremia among HIV-infected smear- negative presumptive tuberculosis patients in Uganda.
    Nakiyingi L; Ssengooba W; Nakanjako D; Armstrong D; Holshouser M; Kirenga BJ; Shah M; Mayanja-Kizza H; Joloba ML; Ellner JJ; Dorman SE; Manabe YC
    BMC Infect Dis; 2015 Feb; 15():62. PubMed ID: 25888317
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Early morning urine collection to improve urinary lateral flow LAM assay sensitivity in hospitalised patients with HIV-TB co-infection.
    Gina P; Randall PJ; Muchinga TE; Pooran A; Meldau R; Peter JG; Dheda K
    BMC Infect Dis; 2017 May; 17(1):339. PubMed ID: 28499418
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Diagnostic accuracy of a rapid urine lipoarabinomannan test for tuberculosis in HIV-infected adults.
    Nakiyingi L; Moodley VM; Manabe YC; Nicol MP; Holshouser M; Armstrong DT; Zemanay W; Sikhondze W; Mbabazi O; Nonyane BA; Shah M; Joloba ML; Alland D; Ellner JJ; Dorman SE
    J Acquir Immune Defic Syndr; 2014 Jul; 66(3):270-9. PubMed ID: 24675585
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Does the use of adjunct urine lipopolysaccharide lipoarabinomannan in HIV-infected hospitalized patients reduce the utilization of healthcare resources? A post hoc analysis of the LAM multi-country randomized controlled trial.
    Naidoo P; Esmail A; Peter JG; Davids M; Fadul M; Dheda K
    Int J Infect Dis; 2019 Feb; 79():37-43. PubMed ID: 30292891
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical outcomes of new algorithm for diagnosis and treatment of Tuberculosis sepsis in HIV patients.
    Byashalira K; Mbelele P; Semvua H; Chilongola J; Semvua S; Liyoyo A; Mmbaga B; Mfinanga S; Moore C; Heysell S; Mpagama S
    Int J Mycobacteriol; 2019; 8(4):313-319. PubMed ID: 31793499
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prognostic value of a quantitative analysis of lipoarabinomannan in urine from patients with HIV-associated tuberculosis.
    Kerkhoff AD; Wood R; Vogt M; Lawn SD
    PLoS One; 2014; 9(7):e103285. PubMed ID: 25075867
    [TBL] [Abstract][Full Text] [Related]  

  • 39. High-sensitivity C-reactive protein in HIV care: Tuberculosis diagnosis and short-term mortality in a cohort of Kenyan HIV patients in the DREAM programme.
    Ciccacci F; Welu B; Ndoi H; Karea I; Orlando S; Brambilla D; Munene K; Giglio P; Opanga B; Ronoh A; Mukwanjagi S; Mwiraria R; Guidotti G; Marazzi MC
    Int J Infect Dis; 2021 Mar; 104():329-334. PubMed ID: 33440261
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Incremental Yield of Including Determine-TB LAM Assay in Diagnostic Algorithms for Hospitalized and Ambulatory HIV-Positive Patients in Kenya.
    Huerga H; Ferlazzo G; Bevilacqua P; Kirubi B; Ardizzoni E; Wanjala S; Sitienei J; Bonnet M
    PLoS One; 2017; 12(1):e0170976. PubMed ID: 28125693
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.